Canonical ingredient
Benzoic acid, 5-(aminosulfonyl)-4-chloro- 2-[(2-furanylmethyl)amino]-
FUROSEMIDE
75 linked products
Official identifiers
Names and synonyms
- Benzoic acid, 5-(aminosulfonyl)-4-chloro- 2-[(2-furanylmethyl)amino]- (en)
- Furosémide (fr)
- Furosémide (fr-CA)
Source-scoped chemical properties
Every value keeps its own authority, licence and retrieval date. Conflicting values are not silently merged.
- canada dsl listing
- listed
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl bioaccumulative
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl inherently toxic aquatic
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets cepa categorization
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets environmental
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets human health
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl persistent
- Yes
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl substance category
- Organics
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
Equivalent concepts in other registries
These links require an exact shared identifier; names alone are never sufficient.
- furosemide
GLOBAL · CAS 54-31-9
Verification source
Safety and technical documents
General references and manufacturer-specific SDS documents are kept separate.
No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.
End-to-end traceability
Only links supported by an identified source are published. Missing evidence remains explicitly unknown.
Evidence still missing
- Country or region of origin
- Raw-material producer
- Ingredient manufacturer
- Distributor
- Transformation steps
Method: a company’s registration country is never used as evidence of a material’s origin.
Products containing this ingredient
APO-FUROSEMIDE
40 · MG
APO-FUROSEMIDE
20 · MG
APO-FUROSEMIDE
80 · MG
AVA-FUROSEMIDE
20 · MG
AVA-FUROSEMIDE
40 · MG
AVA-FUROSEMIDE
80 · MG
BIO-FUROSEMIDE
20 · MG
BIO-FUROSEMIDE
40 · MG
DOM-FUROSEMIDE
20 · MG
DOM-FUROSEMIDE
40 · MG
FUROSEMIDE
20 · MG
FUROSEMIDE
40 · MG
FUROSEMIDE
80 · MG
FUROSEMIDE 20MG TABLETS
20 · MG
FUROSEMIDE 40MG TAB
40 · MG
FUROSEMIDE 40MG TABLETS
40 · MG
FUROSEMIDE INJ 10MG/ML
10 · MG · ML
FUROSEMIDE INJ USP
10 · MG · ML
FUROSEMIDE INJECTION
10 · MG · ML
FUROSEMIDE INJECTION SANDOZ STANDARD
50 · MG · ML
FUROSEMIDE INJECTION SDZ
10 · MG · ML
FUROSEMIDE INJECTION USP
10 · MG · ML
FUROSEMIDE INJECTION USP
20 · MG · 2 · ML
FUROSEMIDE INJECTION USP
10 · MG · ML
FUROSEMIDE INJECTION USP
250 · MG · 25 · ML
FUROSEMIDE INJECTION USP
10 · MG · ML
FUROSEMIDE INJECTION USP
10 · MG · ML
FUROSEMIDE INJECTION, USP
10 · MG · ML
FUROSEMIDE INJECTION, USP
10 · MG · ML
FUROSEMIDE INJECTION, USP
10 · MG · ML
FUROSEMIDE SPECIAL
250 · MG · 25 · ML
FUROSEMIDE SPECIAL INJECTION
250 · MG · 25 · ML
FUROSEMIDE SPECIAL INJECTION
250 · MG · 25 · ML
FUROSEMIDE SPECIAL SDZ
10 · MG · ML
FUROSIDE TAB 20MG
20 · MG
FUROSIDE TAB 40MG
40 · MG
LASIX
20 · MG
LASIX
40 · MG
LASIX - TAB 80MG
80 · MG
LASIX 2G BOL-O-TABS
2 · G
LASIX 40MG TABLETS
40 · MG
LASIX 80MG TABLETS
80 · MG · TAB
LASIX INJECTION 10MG/ML
10 · MG · ML
LASIX INJECTION 10MG/ML - IM IV
10 · MG · ML
LASIX ORAL SOLN 10MG/ML
10 · MG · ML
LASIX ORAL SOLUTION
10 · MG · ML
LASIX ORAL SOLUTION 10MG/ML
10 · MG · ML
LASIX PARENTERAL INJ
20 · MG · 2 · ML